Simvastatin in the prevention of recurrent pancreatitis: a triple-blinded randomised clinical trial (the SIMBA trial)
Hospital General Universitario de Alicante Doctor Balmis · Hospital Clínico Universitario de Valladolid · +34 more institutions
Abstract
Recurrent acute pancreatitis (RAP) or acute-on-chronic flares in chronic pancreatitis (CP) have limited preventive options beyond addressing the underlying aetiology. Statins, due to their anti-inflammatory properties, have been proposed as a potential prophylactic treatment.
We aimed to evaluate whether simvastatin could reduce the recurrence of pancreatitis.
Citation impact
- FWCI
- 101.34
- Percentile
- 100%
- References
- 39
Authors
31- LGLucía Guilabert
Hospital General Universitario de Alicante Doctor Balmis
- KCKarina Cárdenas-Jaen
Hospital General Universitario de Alicante Doctor Balmis
- AVAlicia Vaillo-Rocamora
Hospital General Universitario de Alicante Doctor Balmis
- MLMaría Lourdes Ruiz-Rebollo
Hospital Clínico Universitario de Valladolid
- FBFederico Bolado
Complejo Hospitalario de Navarra, Universidad de Navarra
Topics & keywords
- Simvastatin
- Clinical trial
- MEDLINE
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Randomized controlled trial
- Good health and well-being